Create an alert
to follow the executive moves at Contextual Genomics.

Latest M&A news in Biotechnology.

Ligand Pharmaceuticals has announced the acquisition of Pfenex (posted on Aug 11, 2020).
GeneTech Co and Eurofins have merged (posted on Aug 10, 2020).
JW Therapeutics has announced the acquisition of Eureka Therapeutics (posted on Jul 20, 2020).

Most searched biographies at Contextual Genomics

• Michael Ball, Chief Executive Officer and Director
• James Lumsdaine, Director
• Sue Paish, Chairman of the Board

Click on an executive to view his biography >

Other contacts in the Biotechnology industry

• Tal Zaks - Non-Executive Director at Adaptimmune Therapeutics
• Sylke Hassel - Senior Vice President and Business leader, Global Head of Mammalian and Microbial Business at Lonza
• Monica Pala - Administration Manager at Genextra

Learn more about the Biotechnology industry >

Latest news about Contextual Genomics

Contextual Genomics on Wikipedia, Google News & Yahoo Finance

Contextual Genomics on LinkedIn, Twitter & YouTube

Contextual Genomics has 1,428 competitors including Biogen (United States (USA)), Eurofins (France) and Genentech (United States (USA)). Contextual Genomics is owned by LifeLabs.

Contact by email its executives including Michael Ball

Call Contextual Genomics at +1 778....

View the org chart

Register to receive your alert

Report an error